ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $1.76 Million in Common Shares

Bitget2026/11/06 02:06

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ADMA Biologics President, CEO and director Adam S. Grossman sold 147,000 common shares at $12 on November 5, 2026.
Grossman also exercised stock options for 105,000 common shares at $5.4 per share.
Following the transactions, he directly held 2,070,777 common shares and indirectly held 1,724,383 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-042166), on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $1.76 Million in Common Shares

You may also like

Crypto prices